More obesity drugs are being launched this year following Novo Nordisk and Eli Lilly's previous successes with GLP-1 drugs.

American Merck & Co, known in Europe as MSD, has discontinued the development of vibostolimab and favezelimab, two experimental cancer drugs, after their failure in several trials, according to a ...

Ultimovacs is developing the cancer vaccine UV1, which aims to enhance and improve the effect of immunotherapy in various forms of cancer. Zelluna is developing immunotherapies against solid tumors.

The new factory, including a warehouse, will cover 40,000 square meters. Construction has already begun, and the facility is expected to be completed in 2027, according to a press release. – We are ...

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified ...

Rise (Research Institutes of Sweden) has decided to shut down its entire in vivo operations in Södertälje, where toxicological studies and other types of preclinical studies were conducted on animals.

In 2020, after 26 years at the bottom of the sea, MS Estonia was the subject of a documentary movie which shall throw authorities and common man around the Baltic sea back to square one. The declared ...

MEDLEMSNYHET - The medical technology group Smith+Nephew uses an AI-supported light microscope ZEISS Axio Imager to inspect ...

A new treatment for cystic fibrosis has been approved by the U.S. Food and Drug Administration (FDA).

MEDLEMSNYHET - SignalChem Biotech (part of Sino Biological) offers integrated solutions to support kinase drug discovery, spanning target discovery to compound screening, profiling, and optimization.

Sjukdomars sällsynthet får nu ännu större betydelse när TLV ändrar sina arbetssätt. Förhoppningen är att tillgången till ...

Rådet består sedan innan av ordförande Sven-Eric Söder och ledamöterna Yasmine Bladelius (S), Åsa Gyberg-Karlsson (V), Per ...